Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review

Muhammad Umer Ahmed, Muhammad Hanif, Mukarram Jamat Ali, Muhammad Adnan Haider, Danish Kherani, Gul Muhammad Memon, Amin H. Karim, Abdul Sattar

Research output: Contribution to journalReview articlepeer-review

124 Scopus citations


Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with many neurological symptoms but there is a little evidence-based published material on the neurological manifestations of COVID-19. The purpose of this article is to review the spectrum of the various neurological manifestations and underlying associated pathophysiology in COVID-19 patients. Method: We conducted a review of the various case reports and retrospective clinical studies published on the neurological manifestations, associated literature, and related pathophysiology of COVID-19 using PUBMED and subsequent proceedings. A total of 118 articles were thoroughly reviewed in order to highlight the plausible spectrum of neurological manifestations of COVID 19. Every article was either based on descriptive analysis, clinical scenarios, correspondence, and editorials emphasizing the neurological manifestations either directly or indirectly. We then tried to highlight the significant plausible manifestations and complications that could be related to the pandemic. With little known about the dynamics and the presentation spectrum of the virus apart from the respiratory symptoms, this area needs further consideration. Conclusion: The neurological manifestations associated with COVID-19 such as Encephalitis, Meningitis, acute cerebrovascular disease, and Guillain Barré Syndrome (GBS) are of great concern. But in the presence of life-threatening abnormal vitals in severely ill COVID-19 patients, these are not usually underscored. There is a need to diagnose these manifestations at the earliest to limit long term sequelae. Much research is needed to explore the role of SARS-CoV-2 in causing these neurological manifestations by isolating it either from cerebrospinal fluid or brain tissues of the deceased on autopsy. We also recommend exploring the risk factors that lead to the development of these neurological manifestations.

Original languageEnglish (US)
Article number518
JournalFrontiers in Neurology
StatePublished - May 22 2020


  • COVID-19
  • SARS-CoV-2
  • encephalitis
  • encephalomyelitis
  • neurological manifestations
  • neurotropism

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review'. Together they form a unique fingerprint.

Cite this